Momenta Pharmaceuticals Inc. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Momenta Pharmaceuticals Inc.

MNTA 52.48

0.0%

Oct 2 5:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: tuck who wrote (2516)	9/28/2010 8:55:10 PM
From: DewDiligence_on_SI	of 3027

Agreed that this meeting has little or no consequence for MNTA in the short run. FWIW, I assume that the first few FoB’s approved by the FDA under the new regulatory pathway will require at least one clinical trial to show safety and efficacy. Eventually, the FDA might be willing to entertain a Lovenox-like approval for a protein drug where the review does not include a clinical trial, but I think it will take at least a few years for the FDA to get comfortable with this idea. *Provided that it was characterized by MNTA :-)

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next